A Comparison of Outcomes of ‘Extensor Carpi Ulnaris Tenodesis’ versus ‘No Tenodesis’ after Resection of the Distal Ulna in Patients with Giant Cell Tumor

医学 尺骨 外科 切除术
作者
Badaruddin Sahito,Sheikh Muhammad Ebad Ali,Javeria QAMAR,Muhammad Soughat Katto,Malik Wasim Ahmed,Muhammad Jamil
出处
期刊:The journal of hand surgery [World Scientific]
卷期号:27 (01): 110-116 被引量:2
标识
DOI:10.1142/s2424835522500102
摘要

Background: One of the methods of stabilizing the stump of the ulna following resection of the distal ulna is tenodesis of the extensor carpi ulnaris (ECU). Some studies have recommended stabilization, whereas others have not found it useful. Most of these studies have a mix of different pathologies and often do not have a control group. The aim of this study is to compare the outcomes of ECU tenodesis versus no tenodesis after resection of the distal ulna in patients with grade III giant cell tumor (GCT) of the distal ulna. Methods: The retrospective study included 10 patients with Campanacci grade III GCT of the distal ulna treated by resection of the distal ulna between 2014 and 2019. Patients were stratified into two groups based on whether they underwent ECU tenodesis (n = 5) or no tenodesis (n = 5). The patients were assessed at 6 weeks, 6 months, and 12 months for complications and outcomes using the Mayo wrist score (MWS) and the revised musculoskeletal tumor society score (MSTS). Results: The MWS and the MSTS were significantly better in the ECU tenodesis group at 6 weeks. At 6 months, MWS was similar in both groups, but MSTS continued to be significantly better in ECU tenodesis group. At 12 months, both groups reported similar MWS and MSTS. There were no recurrences in either groups. One patient in the ECU tenodesis group developed ECU tendonitis that resolved with conservative treatment. Conclusions: The outcomes of ECU tenodesis were better in the short term (6 months), although both groups reported similar outcomes at 12 months. Level of Evidence: Level III (Therapeutic).

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
郭子醇发布了新的文献求助10
1秒前
2秒前
明亮若枫发布了新的文献求助20
2秒前
所所应助hey采纳,获得10
2秒前
yy完成签到 ,获得积分10
3秒前
三青发布了新的文献求助30
3秒前
江湖小妖发布了新的文献求助10
3秒前
dada完成签到 ,获得积分10
3秒前
胖三斤发布了新的文献求助10
4秒前
碧蓝的自行车完成签到,获得积分10
4秒前
庞steven完成签到,获得积分10
5秒前
vv发布了新的文献求助10
5秒前
Hello应助小曹君采纳,获得10
5秒前
闪闪芝麻发布了新的文献求助10
5秒前
6秒前
6秒前
李hk发布了新的文献求助10
7秒前
7秒前
8秒前
小蘑菇应助zzz采纳,获得10
8秒前
科研通AI6.1应助时年级采纳,获得10
8秒前
9秒前
buno发布了新的文献求助200
9秒前
土豪的易文完成签到,获得积分10
9秒前
10秒前
10秒前
10秒前
orixero应助李李李采纳,获得10
11秒前
jiangzhishu发布了新的文献求助10
11秒前
11秒前
肥鹏发布了新的文献求助10
12秒前
12秒前
Thi发布了新的文献求助10
13秒前
盐酸小檗碱完成签到,获得积分10
14秒前
在水一方应助方之双采纳,获得10
14秒前
14秒前
15秒前
huihui发布了新的文献求助100
15秒前
高分求助中
Modern Epidemiology, Fourth Edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Digital Twins of Advanced Materials Processing 2000
Propeller Design 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
Handbook of pharmaceutical excipients, Ninth edition 1500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 化学工程 生物化学 物理 计算机科学 内科学 复合材料 催化作用 物理化学 光电子学 电极 冶金 细胞生物学 基因
热门帖子
关注 科研通微信公众号,转发送积分 6011376
求助须知:如何正确求助?哪些是违规求助? 7560434
关于积分的说明 16136728
捐赠科研通 5158063
什么是DOI,文献DOI怎么找? 2762650
邀请新用户注册赠送积分活动 1741401
关于科研通互助平台的介绍 1633620